Blood transfusions and human recombinant erythropoietin in premature newborn infants.
- 1 July 1996
- journal article
- research article
- Published by BMJ in Archives of Disease in Childhood: Fetal & Neonatal
- Vol. 75 (1) , F65-F68
- https://doi.org/10.1136/fn.75.1.f65
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Reducing donor exposure in preterm infants requiring multiple blood transfusions.Archives of Disease in Childhood: Fetal & Neonatal, 1995
- The Role of the Plasma from Platelet Concentrates in Transfusion ReactionsNew England Journal of Medicine, 1994
- A randomized, double-blind, placebo-controlled trial of recombinant erythropietin in treatment of the anemia of bronchopulmonary dysplasiaThe Journal of Pediatrics, 1993
- Erythropoietin, protein, and iron supplementation and the prevention of anaemia of prematurity.Archives of Disease in Childhood, 1993
- Enhancement of erythropoiesis by recombinant human erythropoietin in low birth weight infants: A pilot studyThe Journal of Pediatrics, 1992
- Recombinant human erythropoietin in the anemia of prematurity: Results of a placebo-controlled pilot studyThe Journal of Pediatrics, 1991
- Prediction of the need for transfusion during anemia of prematurityThe Journal of Pediatrics, 1990
- Persistence of cytomegalovirus in mononuclear cells in peripheral blood from blood donors.BMJ, 1989
- Transfusion-Induced Immunologic UnresponsivenessTransfusion Medicine Reviews, 1988
- Prevention of transfusion-acquired cytomegalovirus infections in newborn infantsThe Journal of Pediatrics, 1981